Improving compliance with venous thromboembolism prophylaxis guidelines in obese inpatients.
Adrian CheeHadley BortzJarrod YipJames D McFadyenPublished in: Internal medicine journal (2022)
Obesity is a well-recognised risk factor for venous thromboembolism, and increased dosing of pharmacological prophylaxis is recommended in obese inpatients. We performed a clinical decision support intervention by adjusting order sentences of prophylactic enoxaparin within our electronic medical records, which significantly improved appropriate dosing for thromboprophylaxis in obese inpatients at our institution.